TELIK INC.
TELIK INC. Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20140329754 | COMPOSITIONS AND METHODS FOR TREATING MYELODYSPLASTIC SYNDROME - This invention generally relates to compositions and methods for treating myelodysplastic syndrome. In one embodiment, this invention relates to methods for treating myelodysplastic syndrome with ezatiostat or a salt thereof and lenalidomide. | 11-06-2014 |
20130217653 | FORMULATIONS OF CANFOSFAMIDE AND THEIR PREPARATION - This invention provides stable, lyophilized formulations of canfosfamide as well as the methods of preparation of those stable lyophilized formulations. | 08-22-2013 |
20130184280 | SUBSTITUTED THIAZOLES AS VEGFR2 KINASE INHIBITORS - Disclosed herein are substituted thiazoles and their salts that are VEGFR2 kinase inhibitors, useful in the treatment of cancer. | 07-18-2013 |
20130035389 | METHODS FOR TREATING MYELODYSPLASTIC SYNDROME WITH EZATIOSTAT - This invention relates to methods, assays, devices and systems for identifying patients having a myelodysplastic syndrome for treatment with ezatiostat or a salt thereof, or evaluating the patient's response possibility to the treatment by measuring and evaluating the patient's gene expression profile. This invention also relates to methods of treating myelodysplastic syndromes. | 02-07-2013 |
20120165260 | CRYSTALLINE EZATIOSTAT HYDROCHLORIDE ANSOLVATE - Crystalline ezatiostat hydrochloride ansolvate form D is more stable and/or more soluble that various solvated crystalline polymorphic forms of ezatiostat hydrochloride. | 06-28-2012 |
20120101286 | SUBSTITUTED 4-AMINO-5-BENZOYL-2-(PHENYLAMINO)THIOPHENE-3-CARBONITRILES AND SUBSTITUTED 4-AMINO-5-BENZOYL-2-(PHENYLAMINO)THIOPHENE-3-CARBOXAMIDES AS TUBULIN POLYMERIZATION INHIBITORS - Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides and their salts are tubulin polymerization inhibitors, useful in the treatment of cancer. | 04-26-2012 |